3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Recurrence
1
Obesity
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
glofitamab
2
Cyclophosphamide
2
pembrolizumab
1
obinutuzumab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Weights and Measures
1
Tacrolimus
1
Sirolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Geriatric Assessment
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Activities of Daily Living
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Weights and Measures
×
90 days
×
Clear all
NCT04113226
2026-06-12
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Completed
1 enrolled